Abstract
Visual impairment has been linked to a decline in quality of life (QoL), but limited research has been conducted on real-world visual and humanistic outcomes in patients diagnosed with retinal diseases, including neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have